Cargando…

Antineoplastics: Severe combined immmune dysfunction: case report

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149137/
http://dx.doi.org/10.1007/s40278-018-51597-3
_version_ 1783520745716973568
collection PubMed
description
format Online
Article
Text
id pubmed-7149137
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71491372020-04-13 Antineoplastics: Severe combined immmune dysfunction: case report Reactions Weekly Case Report Springer International Publishing 2018-09-15 2018 /pmc/articles/PMC7149137/ http://dx.doi.org/10.1007/s40278-018-51597-3 Text en © Springer Nature Switzerland AG 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Antineoplastics: Severe combined immmune dysfunction: case report
title Antineoplastics: Severe combined immmune dysfunction: case report
title_full Antineoplastics: Severe combined immmune dysfunction: case report
title_fullStr Antineoplastics: Severe combined immmune dysfunction: case report
title_full_unstemmed Antineoplastics: Severe combined immmune dysfunction: case report
title_short Antineoplastics: Severe combined immmune dysfunction: case report
title_sort antineoplastics: severe combined immmune dysfunction: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149137/
http://dx.doi.org/10.1007/s40278-018-51597-3